Knock-out of CD73 delays the onset of HR-negative breast cancer by reprogramming lipid metabolism and is associated with increased tumor mutational burden

CD73 has a significant role in tumorigenesis driving the reprogramming of lipid metabolism through the regulatory loop with PR and PPARγ in epithelial cells of mammary glands. Low CD73 expression/CD73 KO might enhance mutational burden by disrupting this regulatory loop, delaying the onset of HR-negative tumors. Our results support combining therapy targeting the CD73-adenosine axis and tumor lipidome against HR-negative tumors, especially at their earliest developmental stage.

Authors

Institutions

Publication Details

Journal
Molecular Metabolism
Published
2024-09-19
DOI
https://doi.org/10.1016/j.molmet.2024.102035
Citations
4
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
1.14

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Knock-out of CD73 delays the onset of HR-negative breast cancer by reprogramming lipid metabolism and is associated with increased tumor mutational burden

Paweł Kamil Serafin, Patrycja Koszałka, Kamila Bulak, Adriana Mika et al.
4 citations
Molecular Metabolism
Cancer, Lipids, and Metabolism
1.14
article

Knock-out of CD73 delays the onset of HR-negative breast cancer by reprogramming lipid metabolism and is associated with increased tumor mutational burden

Paweł Kamil Serafin, Patrycja Koszałka, Kamila Bulak, Adriana Mika, Barbara Galikowska‐Bogut, Grzegorz Stasiłojć, Marcin Stanisławowski, Marta Popęda, Leszek Kalinowski, Anna Joanna Zaczek, Marika Bolcewicz, Agata Zwara, Kamila Jendernalik, Tomasz Śledziński, Rafał Sądej, Anna Przychodzka, Wiktoria Laprus
article en
4 citations

Abstract

CD73 has a significant role in tumorigenesis driving the reprogramming of lipid metabolism through the regulatory loop with PR and PPARγ in epithelial cells of mammary glands. Low CD73 expression/CD73 KO might enhance mutational burden by disrupting this regulatory loop, delaying the onset of HR-negative tumors. Our results support combining therapy targeting the CD73-adenosine axis and tumor lipidome against HR-negative tumors, especially at their earliest developmental stage.

Molecular MetabolismVol. 89
University of Life Sciences in Lublin (PL), Gdańsk Medical University (PL)
Narodowe Centrum Nauki, Ministerstwo Edukacji i Nauki, Gdański Uniwersytet Medyczny
Good health and well-being
Openalex Percentile: Top 21%
Cancer, Lipids, and Metabolism
1.14
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.